Cargando…
USP24 promotes drug resistance during cancer therapy
Drug resistance has remained an important issue in the treatment and prevention of various diseases, including cancer. Herein, we found that USP24 not only repressed DNA-damage repair (DDR) activity by decreasing Rad51 expression to cause the tumor genomic instability and cancer stemness, but also i...
Autores principales: | Wang, Shao-An, Young, Ming-Jer, Wang, Yi-Chang, Chen, Shu-Hui, Liu, Chia-Yu, Lo, Yao-An, Jen, Hung-Hsiang, Hsu, Kai-Cheng, Hung, Jan-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408266/ https://www.ncbi.nlm.nih.gov/pubmed/33846536 http://dx.doi.org/10.1038/s41418-021-00778-z |
Ejemplares similares
-
USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy
por: Wang, Shao-An, et al.
Publicado: (2020) -
USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy
por: Wang, Yi-Chang, et al.
Publicado: (2018) -
Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFR(L858R)-lung cancer mice
por: Wang, Yi-Shiang, et al.
Publicado: (2023) -
USP 24-NF 19 : The Official Compendia of Standards.
Publicado: (1999) -
Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression
por: Hung, Chia-Yang, et al.
Publicado: (2017)